9NG

5-bromo-1-{[4-(1H-tetrazol-5-yl)phenyl]methyl}-1'-(thiophene-2-sulfonyl)spiro[indole-3,4'-piperidin]-2(1H)-one

Created:	2017-05-19
Last modified:	2017-07-05

Find Related PDB Entry
1 entries where 9NG is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	0
Bond Count	62
Aromatic Bond Count	22

2D diagram of 9NG

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-bromo-1-{[4-(1H-tetrazol-5-yl)phenyl]methyl}-1'-(thiophene-2-sulfonyl)spiro[indole-3,4'-piperidin]-2(1H)-one
Systematic Name (OpenEye OEToolkits)	5-bromanyl-1-[[4-(1~{H}-1,2,3,4-tetrazol-5-yl)phenyl]methyl]-1'-thiophen-2-ylsulfonyl-spiro[indole-3,4'-piperidine]-2-one
Formula	C₂₄ H₂₁ Br N₆ O₃ S₂
Molecular Weight	585.496
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(N1CCC2(CC1)c1cc(Br)ccc1N(Cc1ccc(cc1)c1nnn[NH]1)C2=O)c1cccs1
SMILES	CACTVS	3.385	Brc1ccc2N(Cc3ccc(cc3)c4[nH]nnn4)C(=O)C5(CCN(CC5)[S](=O)(=O)c6sccc6)c2c1
SMILES	OpenEye OEToolkits	2.0.7	c1cc(sc1)S(=O)(=O)N2CCC3(CC2)c4cc(ccc4N(C3=O)Cc5ccc(cc5)c6[nH]nnn6)Br
Canonical SMILES	CACTVS	3.385	Brc1ccc2N(Cc3ccc(cc3)c4[nH]nnn4)C(=O)C5(CCN(CC5)[S](=O)(=O)c6sccc6)c2c1
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(sc1)S(=O)(=O)N2CCC3(CC2)c4cc(ccc4N(C3=O)Cc5ccc(cc5)c6[nH]nnn6)Br
InChI	InChI	1.06	InChI=1S/C24H21BrN6O3S2/c25-18-7-8-20-19(14-18)24(9-11-30(12-10-24)36(33,34)21-2-1-13-35-21)23(32)31(20)15-16-3-5-17(6-4-16)22-26-28-29-27-22/h1-8,13-14H,9-12,15H2,(H,26,27,28,29)
InChIKey	InChI	1.06	PDMCUTCDLHMYSW-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	126962401

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.